75 related articles for article (PubMed ID: 20093724)
1. Parvalbumin: Targeting calcium handling in cardiac diastolic dysfunction.
Wang W; Martindale J; Metzger JM
Gen Physiol Biophys; 2009; 28 Spec No Focus():F3-6. PubMed ID: 20093724
[TBL] [Abstract][Full Text] [Related]
2. Parvalbumin isoforms for enhancing cardiac diastolic function.
Wang W; Metzger JM
Cell Biochem Biophys; 2008; 51(1):1-8. PubMed ID: 18458829
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes.
Huq F; Lebeche D; Iyer V; Liao R; Hajjar RJ
Circulation; 2004 Jun; 109(22):2780-5. PubMed ID: 15173024
[TBL] [Abstract][Full Text] [Related]
4. Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action.
Day SM; Coutu P; Wang W; Herron T; Turner I; Shillingford M; Lacross NC; Converso KL; Piao L; Li J; Lopatin AN; Metzger JM
Physiol Genomics; 2008 May; 33(3):312-22. PubMed ID: 18334547
[TBL] [Abstract][Full Text] [Related]
5. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.
Coutu P; Bennett CN; Favre EG; Day SM; Metzger JM
Circ Res; 2004 May; 94(9):1235-41. PubMed ID: 15059934
[TBL] [Abstract][Full Text] [Related]
6. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
Yeh YH; Wakili R; Qi XY; Chartier D; Boknik P; Kääb S; Ravens U; Coutu P; Dobrev D; Nattel S
Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):93-102. PubMed ID: 19808399
[TBL] [Abstract][Full Text] [Related]
7. Parvalbumin gene delivery improves diastolic function in the aged myocardium in vivo.
Michele DE; Szatkowski ML; Albayya FP; Metzger JM
Mol Ther; 2004 Aug; 10(2):399-403. PubMed ID: 15294186
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
9. Parvalbumin isoforms differentially accelerate cardiac myocyte relaxation kinetics in an animal model of diastolic dysfunction.
Rodenbaugh DW; Wang W; Davis J; Edwards T; Potter JD; Metzger JM
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1705-13. PubMed ID: 17545482
[TBL] [Abstract][Full Text] [Related]
10. Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes.
Wahr PA; Michele DE; Metzger JM
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11982-5. PubMed ID: 10518562
[TBL] [Abstract][Full Text] [Related]
11. Gene Transfer of Calcium-Binding Proteins into Adult Cardiac Myocytes.
Thompson BR; Cohen H; Angulski ABB; Metzger JM
Methods Mol Biol; 2019; 1929():187-205. PubMed ID: 30710274
[TBL] [Abstract][Full Text] [Related]
12. In vivo gene transfer of parvalbumin improves diastolic function in aged rat hearts.
Schmidt U; Zhu X; Lebeche D; Huq F; Guerrero JL; Hajjar RJ
Cardiovasc Res; 2005 May; 66(2):318-23. PubMed ID: 15820200
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction.
Hirsch JC; Borton AR; Albayya FP; Russell MW; Ohye RG; Metzger JM
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2314-21. PubMed ID: 15148059
[TBL] [Abstract][Full Text] [Related]
14. [Molecular mechanism underlying calcium handling in diastolic heart failure].
Zhong M; Zhang Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):669-72. PubMed ID: 11798946
[TBL] [Abstract][Full Text] [Related]
15. A Ca(2+)-binding protein with numerous roles and uses: parvalbumin in molecular biology and physiology.
Arif SH
Bioessays; 2009 Apr; 31(4):410-21. PubMed ID: 19274659
[TBL] [Abstract][Full Text] [Related]
16. Calcium mishandling in diastolic dysfunction: mechanisms and potential therapies.
Asp ML; Martindale JJ; Heinis FI; Wang W; Metzger JM
Biochim Biophys Acta; 2013 Apr; 1833(4):895-900. PubMed ID: 23022395
[TBL] [Abstract][Full Text] [Related]
17. Effects of Modified Parvalbumin EF-Hand Motifs on Cardiac Myocyte Contractile Function.
Asp ML; Sjaastad FV; Siddiqui JK; Davis JP; Metzger JM
Biophys J; 2016 May; 110(9):2094-105. PubMed ID: 27166817
[TBL] [Abstract][Full Text] [Related]
18. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.
Martos R; Baugh J; Ledwidge M; O'Loughlin C; Conlon C; Patle A; Donnelly SC; McDonald K
Circulation; 2007 Feb; 115(7):888-95. PubMed ID: 17283265
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyocyte stiffness in diastolic heart failure.
Borbély A; van der Velden J; Papp Z; Bronzwaer JG; Edes I; Stienen GJ; Paulus WJ
Circulation; 2005 Feb; 111(6):774-81. PubMed ID: 15699264
[TBL] [Abstract][Full Text] [Related]
20. Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance.
Wang W; Barnabei MS; Asp ML; Heinis FI; Arden E; Davis J; Braunlin E; Li Q; Davis JP; Potter JD; Metzger JM
Nat Med; 2013 Mar; 19(3):305-12. PubMed ID: 23396207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]